Physician profile
Tuo Chen
NPI 1609338870
$1,497.36
in general payments reported to CMS, 2019-2025
11 companies · $601 in 2025
The $601 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.19 · 2024: $874 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.28 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $201.30 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $163.35 | 2024-2025 | Ozempic, Rybelsus |
| Celltrion USA INC. | $124.90 | 2024 | Zymfentra |
| Gilead Sciences, INC. | $82.46 | 2025 | |
| Pfizer INC. | $57.74 | 2024 | |
| Exact Sciences Corporation | $56.11 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $20.92 | 2025 | Gemtesa |
| Seqirus USA INC | $18.74 | 2025 | Flucelvax |
| Amgen INC. | $18.45 | 2024 | Prolia, Evenity |
| Ibsa Pharma INC. | $17.11 | 2025 | Tirosint, Licart, Flector |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuo Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.